Compare CVS Health Corp (CVS) vs T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs T-Rex 2X Inverse MSTR Daily Target ETF — how do they compare? CVS Health Corp trades at $93.55 (market cap $119.58B), while T-Rex 2X Inverse MSTR Daily Target ETF trades at $11.33. The key difference: CVS Health Corp pays a 2.84% dividend while T-Rex 2X Inverse MSTR Daily Target ETF pays none, and CVS Health Corp is trading nearer its 52-week high, T-Rex 2X Inverse MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals.
| CVS | MSTZ | |
|---|---|---|
Market Cap | $119.58B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $110.60 | $27.92 |
52-Week Low | $65.51 | $3.88 |
Enterprise Value | $181.93B | — |
Dividend Yield | 2.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.67, down slightly by 0.03% today. The stock shows strong fundamental momentum with recent quarterly earnings beats, including Q2 2026 EPS of $2.58 versus $1.87 expected, and raised 2026 guidance. Valuation metrics appear reasonable with a P/E of 24.67 and P/S of 0.29. Technical indicators are mixed with a bullish overall signal but bearish moving averages, with key support at $95 and resistance at $96.
The outlook for CVS is positive, supported by earnings strength and analyst consensus, but risks include margin pressure and rising debt levels. The consensus price target of $115.90 implies significant upside, though investors should monitor execution on guidance and healthcare regulatory changes.
MSTZ trades at $11.09, up 2.5% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. Key financial ratios are unavailable, limiting fundamental clarity. Recent news highlights ETF performance unrelated to MSTZ, with no direct company updates found.
The outlook remains cautious due to weak technical momentum and lack of fundamental data. Risks include market volatility and unverified financial health. Investors need current earnings reports and analyst coverage to assess opportunities amid the bearish technical setup.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →
